UK-based specialty pharma business Kelso Pharma has appointed Bee Koen Low as its first chief operating officer (COO).

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

The American medicines regulator will convene its vaccine advisory committee on May 22 to weigh in on which strains should be ...

US antivirals giant Gilead Sciences (Nasdaq: GILD) yesterday announced a substantial investment plan, noting that it is ...

Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on ...

Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Israel’s Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2025.

Sino American biotech BeiGene (Nasdaq: ONC; HKEX: 06160), a global oncology company that will change its name to BeOne ...

US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for ...

A Seattle-based preclinical biotech comany developing novel neuroplastogens to treat neuropsychiatric and neurodegenerative ...